A 52-year-old man with a 15-year history of type 2 diabetes mellitus presents with progressive renal dysfunction. Renal biopsy shows nodular glomerulosclerosis with acellular hyaline material in the glomeruli. What is the most common cause of end-stage renal disease in diabetic patients?

Explanation

## Most Common Cause of ESRD in Diabetes **Key Point:** Diabetic nephropathy is the single most common cause of end-stage renal disease (ESRD) in both developed and developing countries, accounting for approximately 30–40% of all ESRD cases globally and up to 50% in India. ### Pathological Features of Diabetic Nephropathy | Feature | Description | |---------|-------------| | **Glomerular lesion** | Nodular glomerulosclerosis (Kimmelstiel-Wilson lesion) | | **Composition** | Acellular hyaline material (PAS-positive, diastase-resistant) | | **Location** | Peripheral lobules of glomeruli | | **Associated findings** | Basement membrane thickening, mesangial expansion, hyaline arteriolosclerosis | ### Mechanism of Diabetic Nephropathy Progression ```mermaid flowchart TD A[Hyperglycemia]:::outcome --> B[Advanced Glycation End Products]:::outcome A --> C[Protein Kinase C Activation]:::outcome B --> D[Glomerular Basement Membrane Thickening]:::action C --> E[Mesangial Expansion]:::action D --> F[Nodular Glomerulosclerosis]:::outcome E --> F F --> G[Proteinuria]:::outcome G --> H[Progressive Renal Dysfunction]:::outcome H --> I[End-Stage Renal Disease]:::urgent ``` **High-Yield:** The Kimmelstiel-Wilson nodule (nodular glomerulosclerosis) is pathognomonic for diabetic nephropathy and represents the hallmark histological finding on renal biopsy. **Clinical Pearl:** Diabetic nephropathy typically progresses through stages: hyperfiltration → microalbuminuria → overt proteinuria → declining GFR → ESRD. Early intervention with ACE inhibitors or ARBs can slow progression significantly. **Mnemonic: KDIGO Stages of CKD in Diabetes** — Stage 1 (eGFR >90 with albuminuria), Stage 2 (eGFR 60–89 with albuminuria), Stage 3a (eGFR 45–59), Stage 3b (eGFR 30–44), Stage 4 (eGFR 15–29), Stage 5 (eGFR <15). ### Why Diabetic Nephropathy Dominates - Affects 20–40% of all diabetic patients (Type 1 and Type 2) - Present in up to 50% of patients with T1DM after 10 years - In India, diabetes is the leading cause of ESRD, surpassing glomerulonephritis - Hyperglycemia drives both glomerular and tubular injury through multiple pathways (polyol pathway, AGE formation, PKC activation, ROS generation) [cite:Robbins 10e Ch 20]